Table of Contents
- Chapter 1. Research Methodology and Scope
- Market Segmentation and Scope
- Regional Coverage
- Objectives
- Research Methodology
- Chapter 2. Executive Summary
- Market Landscape
- Market Size & Forecast
- Competitive Landscape
- Chapter 3. End Stage Renal Disease Market: Treatment Type Segment Analysis
- Treatment Type Market Size (US$), CAGR (%), and Forecast (2022-2030)
- Treatment Type Definitions, Technology Landscape
- Treatment Type Market Drivers
- Product Launches
- Technology Launches
- Treatment Type Market Restraints
- Chapter 4. End Stage Renal Disease Market: Products & Services Segment Analysis
- Products & Services Market Size (US$), CAGR (%), and Forecast (2022-2030)
- Products & Services Definitions, Technology Landscape
- Products & Services Market Drivers
- Product Launches
- Technology Launches
- Products & Services Market Restraints
- Chapter 5. End Stage Renal Disease Market: End User Segment Analysis
- End User Market Size (US$), CAGR (%), and Forecast (2022-2030)
- End User Definitions, Technology Landscape
- End User Market Drivers
- Product Launches
- Technology Launches
- End User Market Restraints
- Chapter 6. End Stage Renal Disease Market: Setting Segment Analysis
- Setting Market Size (US$), CAGR (%), and Forecast (2022-2030)
- Setting Definitions, Technology Landscape
- Setting Market Drivers
- Product Launches
- Technology Launches
- Setting Market Restraints
- Chapter 7. End Stage Renal Disease Market: Regional Analysis
- North America
- North America Market Size (US$), CAGR (%), and Forecast (2022-2030)
- North America Definitions, Technology Landscape
- North America Market Drivers
- North America Market Restraints
- Country Outlook
- U.S.
- Canada
- Europe
- Europe Market Size (US$), CAGR (%), and Forecast (2022-2030)
- Europe Definitions, Technology Landscape
- Europe Market Drivers
- Europe Market Restraints
- Country Outlook
- UK
- Germany
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific
- Asia Pacific Market Size (US$), CAGR (%), and Forecast (2022-2030)
- Asia Pacific Definitions, Technology Landscape
- Asia Pacific Market Drivers
- Asia Pacific Market Restraints
- Country Outlook
- China
- Japan
- India
- South Korea
- Australia
- ASEAN
- Rest of APAC
- Latin America
- Latin America Market Size (US$), CAGR (%), and Forecast (2022-2030)
- Latin America Definitions, Technology Landscape
- Latin America Market Drivers
- Latin America Market Restraints
- Country Outlook
- Brazil
- Argentina
- Colombia
- Rest of LATAM
- Middle East & Africa
- Middle East & Africa Market Size (US$), CAGR (%), and Forecast (2022-2030)
- Middle East & Africa Definitions, Technology Landscape
- Middle East & Africa Market Drivers
- Middle East & Africa Market Restraints
- Country Outlook
- Nigeria
- Saudi Arabia
- GCC
- Rest of the Countries
- North America
- Chapter 8. End Stage Renal Disease Market: Competitive Landscape
- Fresenius Medical Care
- Company Overview
- Financial Overview
- Product Portfolio
- Strategies
- DaVita
- Company Overview
- Financial Overview
- Product Portfolio
- Strategies
- Baxter
- Company Overview
- Financial Overview
- Product Portfolio
- Strategies
- B. Braun
- Company Overview
- Financial Overview
- Product Portfolio
- Strategies
- Nipro Corporation
- Company Overview
- Financial Overview
- Product Portfolio
- Strategies
- Medtronic
- Company Overview
- Financial Overview
- Product Portfolio
- Strategies
- Nikkiso
- Company Overview
- Financial Overview
- Product Portfolio
- Strategies
- Asahi Kasei
- Company Overview
- Financial Overview
- Product Portfolio
- Strategies
- Toray
- Company Overview
- Financial Overview
- Product Portfolio
- Strategies
- NxStage Medical
- Company Overview
- Financial Overview
- Product Portfolio
- Strategies
- Research Methodology
- Primary Research
- Secondary Research
- Assumptions
- IDataAcumen Analysis
- Paid Databases
- Appendix
- About Us
Frequently Asked Questions
The ESRD market size was valued at USD 80.0 billion in 2023.
Rising prevalence of diabetes and hypertension, technological advancements in dialysis products, favorable reimbursement policies, emerging home-based dialysis trend.
High treatment costs, shortage of skilled nephrologists, complications and comorbidities associated with ESRD treatment, stringent regulatory approvals.
The hemodialysis segment leads the ESRD market.
Fresenius Medical Care, DaVita, Baxter, B.Braun, Nipro, Medtronic, Nikkiso, Asahi Kasei, Toray, NxStage Medical.
The ESRD market is projected to reach USD 120.3 billion by 2030, growing at a CAGR of 6% during 2023-2030.
The key drivers are rising ESRD prevalence, technology innovation in dialysis products, patient-centric approaches, partnerships between device makers and dialysis providers.